Skip to main content

Want a detailed portfolio tracker?

Caris Life Sciences (CAI) Income Statement (2024 - 2025)

Income Statement report data from Jun 30, 2024 to Dec 31, 2025 for Caris Life Sciences (CAI).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024
Revenue and COGS
Total Revenue
293M
(+35.08%)
217M
(+19.53%)
181M
(+50.02%)
121M
(+18.99%)
102M
(+1.57%)
100M
Operating Expenses
Research And Development
32M
(+47.32%)
22M
(-13.69%)
25M
(+8.58%)
23M
(-16.53%)
28M
(+11.50%)
25M
Selling General And Administrative
57M
(+8.74%)
52M
(-19.26%)
64M
(+23.50%)
52M
(+27.59%)
41M
(-0.54%)
41M
Operating Expenses
204M
(+11.02%)
184M
(-7.62%)
199M
(+11.47%)
179M
(+10.10%)
162M
(-2.75%)
167M
Depreciation And Amortization
4.27M
(-12.86%)
4.90M
(-23.44%)
6.40M
(-9.22%)
7.05M
(-32.86%)
11M
(-9.48%)
12M
Operating Income
Operating Income
88M
(+170.86%)
33M-17.99M
(-68.96%)
-57.95M
(-4.75%)
-60.84M
(-9.21%)
-67.01M
Ebit
88M
(+170.86%)
33M-17.99M
(-68.96%)
-57.95M
(-4.75%)
-60.84M
(-9.21%)
-67.01M
EBITDA
93M
(+146.88%)
38M-11.59M
(-77.23%)
-50.91M
(+1.13%)
-50.34M
(-9.15%)
-55.41M
Other Income / Expenses
Interest Expense
11M
(-16.00%)
14M
(-29.69%)
19M
(+50.35%)
13M
(-7.40%)
14M
(+0.95%)
14M
Other Non Operating Income
-20.56M
(+22744.44%)
-90.00K
(-99.51%)
-18.34M
(+91600.00%)
-20.00K40K-140.00K
Net Income
Income Before Tax
82M
(+236.87%)
24M-71.79M
(-30.02%)
-102.58M
(+51.45%)
-67.73M
(+2.33%)
-66.19M
Net Income From Continuing Operations
82M
(+236.87%)
24M-71.79M
(-30.02%)
-102.58M
(+51.45%)
-67.73M
(+2.33%)
-66.19M
Net Income
82M
(+236.87%)
24M-71.79M
(-30.02%)
-102.58M
(+51.45%)
-67.73M
(+2.33%)
-66.19M
Comprehensive Income Net Of Tax
-67.36M24M-71.37M
(-30.40%)
-102.55M
(+51.14%)
-67.85M
(+2.66%)
-66.09M